An in-source multiple collision-neutral loss filtering based nontargeted metabolomics approach for the comprehensive analysis of malonyl-ginsenosides from Panax ginseng, P. quinquefolius, and P. notoginseng

Analytica Chimica Acta

Volumn 952, Issue , 2017, Pages 59-70

  Shi, Xiao jian ^a,b   Yang, Wen zhi ^b   Qiu, Shi ^b   Yao, Chang liang ^b   Shen, Yao ^b   Pan, Hui qin ^b   Bi, Qi rui ^a,b   Yang, Min ^b   Wu, Wan ying ^b   Guo, De an ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Chemical marker; Improved nontargeted metabolomics; In source multiple collision neutral loss filtering; Malonyl ginsenoside; Panax

Indexed keywords

CARBON DIOXIDE; IONS; METABOLITES;

CHEMICAL MARKERS; GINSENOSIDES; METABOLOMICS; MULTIPLE COLLISIONS; PANAX;

PHARMACODYNAMICS;

ANTIDIABETIC AGENT; GINSENG EXTRACT; GINSENOSIDE; MALONYL FLORAL GINSENOSIDE RB 2; MALONYL FLORAL GINSENOSIDE RC 1; MALONYL FLORAL GINSENOSIDE RC 2; MALONYL FLORAL GINSENOSIDE RC 3; MALONYL FLORAL GINSENOSIDE RD 1; MALONYL FLORAL GINSENOSIDE RD 2; MALONYL FLORAL GINSENOSIDE RD 4; MALONYL FLORAL GINSENOSIDE RD 5; MALONYL GINSENOSIDE DERIVATIVE; MALONYL GINSENOSIDE RB 2; MALONYL GINSENOSIDE RC; MALONYL GINSENOSIDE RD; MALONYL GINSENOSIDE RE 1; MALONYL GINSENOSIDE RE 2; PANAX NOTOGINSENG EXTRACT; PANAX QUINQUEFOLIUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIDIABETIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; HYDROLYSIS; INSOURCE MULTIPLE COLLISION NEUTRAL LOSS FILTERING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; METABOLOMICS; PANAX NOTOGINSENG; PANAX QUINQUEFOLIUS; PRIORITY JOURNAL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMISTRY; CLASSIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PANAX; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GINSENOSIDES; METABOLOMICS; PANAX; TANDEM MASS SPECTROMETRY;

EID: 85006476685     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2016.11.032     Document Type: Article

References (36)

1. [1] Johnson, C.H., Ivanisevic, J., Siuzdak, G., Metabolomics: beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17 (2016), 451–459.
2. [2] Wang, X.J., Yang, B., Sun, H., Zhang, A.H., Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography-mass spectrometry-based comprehensive metabolomic profiling and pathways analysis of biological data sets. Anal. Chem. 84 (2012), 428–439.
3. [3] Luo, P., Yu, H.Y., Zhao, X.J., Bao, Y.Q., Hong, C.S., Zhang, P., Tu, Y.F., Yin, P.Y., Gao, P., Wei, L., Zhuang, Z.P., Jia, W.P., Xu, G.W., Metabolomics study of Roux-en-Y gastric bypass surgery (RYGB) to treat type 2 diabetes patients based on ultra performance liquid chromatography-mass spectrometry. J. Proteome Res. 15 (2016), 1288–1299.
4. [4] Wong, J.M.T., Malec, P.A., Mabrouk, O.S., Ro, J., Dus, M., Kennedy, R.T., Benzoyl chloride derivatization with liquid chromatography-mass spectrometry for targeted metabolomics of neurochemicals in biological samples. J. Chromatogr. A 1446 (2016), 78–90.
5. [5] Yang, M.X., Yu, Z., Deng, S.F., Chen, X.M., Chen, L., Guo, Z.Y., Zheng, H., Chen, L., Cai, D.J., Wen, B., Wu, Q.F., Liang, F.R., A targeted metabolomics MRM-MS study on identifying potential hypertension biomarkers in human plasma and evaluating acupuncture effects. Sci. Rep., 2016, 25871.
6. [6] Wagner, S., Scholz, K., Donegan, M., Burton, L., Wingate, J., Völkel, W., Metabolomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Anal. Chem. 78 (2006), 1296–1305.
7. [7] Teichert, F., Winkler, S., Keun, H.C., Steward, W.P., Gescher, A.J., Farmer, P.B., Singh, R., Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometry, Rapid Commun. Mass Spectrom. 25 (2011), 2071–2082.
8. [8] Chen, S.L., Kong, H.W., Lu, X., Li, Y., Yin, P.Y., Zeng, Z.D., Xu, G.W., Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry. Anal. Chem. 85 (2013), 8326–8333.
9. [9] Wang, Y., Liu, F., Li, P., He, C.W., Wang, R.B., Su, H.X., Wan, J.B., An improved pseudotargeted metabolomics approach using multiple ion monitoring with time-staggered ion lists based on ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Anal. Chim. Acta 927 (2016), 82–88.
10. [10] Qi, L.W., Wang, C.Z., Yuan, C.S., Isolation and analysis of ginseng: advances and challenges. Nat. Prod. Rep. 28 (2011), 467–495.
11. [11] Yang, W.Z., Hu, Y., Wu, W.Y., Ye, M., Guo, D.A., Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity. Phytochemistry 106 (2014), 7–24.
12. [12] Kim, J.H., Cardiovascular diseases and Panax ginseng: a review on molecular mechanisms and medicinal applications. J. Ginseng. Res. 36 (2012), 16–26.
13. [13] Qi, L.W., Wang, C.Z., Yuan, C.S., Ginsenosides from American ginseng: chemical and pharmacological diversity. Phytochemistry 72 (2011), 689–699.
14. [14] Liu, J.J., Wang, Y.T., Qin, L., Yu, Y.Y., Wang, C.M., Saponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases. Expert Opin. Investig. Drugs 23 (2014), 523–539.
15. [15] Yang, W.Z., Ye, M., Qiao, X., Liu, C.F., Miao, W.J., Bo, T., Tao, H.Y., Guo, D.A., A strategy for efficient discovery of new natural compounds by integrating orthogonal column chromatography and liquid chromatography/mass spectrometry analysis: its application in Panax ginseng, Panax quinquefolium and Panax notoginseng to characterize 437 potential new ginsenosides. Anal. Chim. Acta 739 (2012), 56–66.
16. [16] Kim, S., Shin, B.K., Lim, D.K., Yang, T.J., Lim, J., Park, J.H., Kwon, S.W., Expeditions discrimination of four species of the Panax genus using direct infusion-MS/MS combined with multivariate statistical analysis. J. Chromatogr. B 1002 (2015), 329–336.
17. [17] Chen, P., Harnly, J.M., Harrington, P.D., Flow injection mass spectrometric fingerprinting and multivariate analysis for differentiation of three Panax species. J. AOAC Int. 94 (2011), 90–99.
18. [18] Yang, W.Z., Qiao, X., Li, K., Fan, J.R., Bo, T., Guo, D.A., Ye, M., Identification and differentiation of Panax ginseng, Panax quinquefolium, and Panax notoginseng by monitoring multiple diagnostic chemical markers. Acta Pharm. Sin. B 6 (2016), 568–575.
19. [19] Liu, Z., Wang, L.J., Li, X., Hu, J.N., Chen, Y., Ruan, C.C., Sun, G.Z., Hypoglycemic effects of malonyl-ginsenosides extracted from roots of Panax ginseng on streptozotocin-induced diabetic mice. Phytother. Res. 23 (2009), 1426–1430.
20. [20] Liu, Z., Li, W., Li, X., Zhang, M., Chen, L., Zheng, Y.N., Sun, G.Z., Ruan, C.C., Antidiabetic effects of malonyl ginsenosides from Panax ginseng on type 2 diabetic rats induced by high-fat diet and streptozotocin. J. Ethnopharmacol. 145 (2013), 233–240.
21. [21] Kite, G.C., Howes, M.J.R., Leon, C.J., Simmonds, M.S.J., Liquid chromatography/mass spectrometry of malonyl-ginsenosides in the authentication of ginseng, Rapid Commun. Mass Spectrom. 17 (2003), 238–244.
22. [22] Liu, Z., Li, Y., Li, X., Ruan, C.C., Wang, L.J., Sun, G.Z., The effects of dynamic changes of malonyl ginsenosides on evaluation and quality control of Panax ginseng C.A. Meyer. J. Pharm. Biomed. Anal. 64–65 (2012), 56–63.
23. [23] Wan, J.Y., Fan, Y., Yu, Q.T., Ge, Y.Z., Yan, C.P., Alolga, R.N., Li, P., Ma, Z.H., Qi, L.W., Integrated evaluation of malonyl ginsenosides, amino acids and polysaccharides in fresh and processed ginseng. J. Pharm. Biomed. Anal. 107 (2015), 89–97.
24. 2, Rc, and Rd, four new malonylated dammarane-type triterpene oligoglycosides from Ginseng Radix. Chem. Pharm. Bull. 31 (1983), 3353–3356.
25. 4 from the root of Panax ginseng. Chem. J. Chin. Univ. 28 (2007), 1316–1318.
26. [26] Ruan, C.C., Liu, Z., Li, X., Liu, X., Wang, L.J., Pan, H.Y., Zheng, Y.N., Sun, G.Z., Zhang, Y.S., Zhang, L.X., Isolation and characterization of a new ginsenoside from the fresh root of Panax ginseng. Molecules 15 (2010), 2319–2325.
27. 13C-NMR spectral assignment of five malonyl ginsenosides from the fresh flower buds of Panax ginseng. J. Ginseng Res. 40 (2016), 245–250.
28. [28] Dai, W.D., Yin, P.Y., Zeng, Z.D., Kong, H.W., Tong, H.W., Xu, Z.L., Lu, X., Lehmann, R., Xu, G.W., Nontargeted modification-specific metabolomics study based on liquid chromatography-high-resolution mass spectrometry. Anal. Chem. 86 (2014), 9146–9153.
29. [29] Qiu, S., Yang, W.Z., Shi, X.J., Yao, C.L., Yang, M., Liu, X., Jiang, B.H., Wu, W.Y., Guo, D.A., A green protocol for efficient discovery of novel natural compounds: characterization of new ginsenosides from the stems and leaves of Panax ginseng as a case study. Anal. Chim. Acta 893 (2015), 65–76.
30. [30] Lai, C.J.S., Tan, T., Zeng, S.L., Qi, L.W., Liu, X.G., Dong, X., Li, P., Liu, E.H., An integrated high resolution mass spectrometric data acquisition method for rapid screening of saponins in Panax notoginseng (Sanqi). J. Pharm. Biomed. Anal. 109 (2015), 184–191.
31. [31] Yang, W.Z., Bo, T., Ji, S., Qiao, X., Guo, D.A., Ye, M., Rapid chemical profiling of saponins in the flower buds of Panax notoginseng by integrating MCI gel column chromatography and liquid chromatography/mass spectrometry analysis. Food Chem. 139 (2013), 762–769.
32. [32] Zhang, J.Y., Wang, Z.J., Zhang, Q., Wang, F., Ma, Q., Lin, Z.Z., Lu, J.Q., Qiao, Y.J., Rapid screening and identification of target constituents using full scan-parent ions list-dynamic exclusion acquisition coupled to diagnostic product ions analysis on a hybrid LTQ-Orbitrap mass spectrometer. Talanta 124 (2014), 111–122.
33. [33] Yang, W.Z., Wu, W.Y., Yang, M., Guo, D.A., Elucidation of the fragmentation pathways of a complex 3,7-O-glycosyl flavonol by CID, HCD, and PQD on an LTQ-Orbitrap Velos Pro hybrid mass spectrometer. Chin. J. Nat. Med. 13 (2015), 867–872.
34. [34] Przybylski, C., Bonnet, V., Discrimination of cyclic and linear oligosaccharides by tandem mass spectrometry using collision-induced dissociation (CID), pulsed-Q-dissociation (PQD) and the high-energy C-trap dissociation modes, Rapid Commun. Mass Spectrom. 27 (2013), 75–87.
35. [35] Yang, W.Z., Zhang, J.X., Yao, C.L., Qiu, S., Chen, M., Pan, H.Q., Shi, X.J., Wu, W.Y., Guo, D.A., Method development and application of offline two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry-fast data directed analysis for comprehensive characterization of the saponins from Xueshuantong Injection. J. Pharm. Biomed. Anal. 128 (2016), 322–332.
36. [36] Yoshikawa, M., Murakami, T., Ueno, T., Hirokawa, N., Yashiro, K., Murakami, N., Yamahara, J., Matsuda, H., Saijoh, R., Tanaka, O., Bioactive saponin and glycosides. IX. 1) Notoginseng (2): structures of five new dammarane-type triterpene oligoglycosides, notoginsenosides-E, -G, -H, -I, and -J, and a novel acetylenic fatty acid glycoside, notoginsenic acid β-sophoroside, from the dried root of Panax notoginseng (Burk.) F. H. Chen. Chem. Pharm. Bull. 45 (1997), 1056–1062.